Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNABW) Other Non-Current Liabilities (2020 - 2025)

Historic Other Non-Current Liabilities for Ginkgo Bioworks Holdings (DNABW) over the last 6 years, with Q3 2025 value amounting to $17.2 million.

  • Ginkgo Bioworks Holdings' Other Non-Current Liabilities fell 291.39% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year decrease of 291.39%. This contributed to the annual value of $16.6 million for FY2024, which is 3215.73% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Other Non-Current Liabilities of $17.2 million as of Q3 2025, which was down 291.39% from $17.9 million recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Other Non-Current Liabilities peaked at $212.9 million during Q3 2021, and registered a low of $15.4 million during Q1 2025.
  • For the 5-year period, Ginkgo Bioworks Holdings' Other Non-Current Liabilities averaged around $53.1 million, with its median value being $24.9 million (2024).
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Other Non-Current Liabilities surged by 438014.51% in 2021, and later plummeted by 8133.75% in 2022.
  • Ginkgo Bioworks Holdings' Other Non-Current Liabilities (Quarter) stood at $135.8 million in 2021, then plummeted by 77.04% to $31.2 million in 2022, then decreased by 21.67% to $24.4 million in 2023, then plummeted by 32.16% to $16.6 million in 2024, then rose by 3.52% to $17.2 million in 2025.
  • Its last three reported values are $17.2 million in Q3 2025, $17.9 million for Q2 2025, and $15.4 million during Q1 2025.